Summary
The U.S. FDA has approved Moderna's first mRNA flu shot, mFlusiva, for adults aged 50 to 64 with traditional approval and for those 65 and older with accelerated approval.
Moderna's mRNA Flu Shot, mFlusiva, Receives FDA Approval
HyperFast News
Related news
FDA Identifies Salmonella Outbreak Linked to Broccoli Sprouts
19 Sept 2026, 1:01 am · News
Cyclospora Outbreak Declared Over by FDA, Origin of 13,000 Cases Still Unknown
19 Sept 2026, 1:01 am · News
FDA Suspends Licenses of IRCTC Supplier, 3 ISKCON Food Establishments in Mumbai Over Violations
19 Sept 2026, 1:01 am · News
